NCT04251364View on ClinicalTrials.gov

Treatment of Chronic Mountain Sickness

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 15, 2020

Primary Completion Date

October 30, 2021

Study Completion Date

December 30, 2021

Conditions
Hypoxia, Altitude
Interventions
DRUG

Acetazolamide

Daily acetazolamide pill intake

DRUG

Atorvastatin

Daily atorvastatin pill intake

DRUG

Placebo oral tablet

Daily placebo pill intake

Trial Locations (1)

38130

Association EXALT, UM Sport Pathologies, Hôpital Sud, Avenue Kimberley, Échirolles

All Listed Sponsors
lead

Centre d'Expertise sur l'Altitude EXALT

OTHER

NCT04251364 - Treatment of Chronic Mountain Sickness | Biotech Hunter | Biotech Hunter